Neuroscientific Biopharmaceuticals Ltd.'s market cap is currently AU$5.49M. The company's EPS TTM is AU$0.002; its P/E ratio is 16.82; Neuroscientific Biopharmaceuticals Ltd. is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Income Statement
Total Revenue	AU$ 0.00	AU$ 4.95M	AU$ 0.00	AU$ 958.77K	AU$ 0.00
Gross Profit	AU$ -91.34K	AU$ 4.90M	AU$ -64.92K	AU$ 897.36K	AU$ -56.66K
Operating Income	AU$ -2.06M	AU$ -6.12M	AU$ -10.50M	AU$ -4.22M	AU$ -2.94M
EBITDA	AU$ -1.80M	AU$ -5.96M	AU$ -10.37M	AU$ -3.12M	AU$ -2.81M
Net Income	AU$ 324.21K	AU$ -1.07M	AU$ -10.44M	AU$ -3.18M	AU$ -2.87M
Balance Sheet
Cash & Short-Term Investments	AU$ 4.95M	AU$ 4.91M	AU$ 7.22M	AU$ 14.16M	AU$ 3.29M
Total Assets	AU$ 5.44M	AU$ 5.29M	AU$ 7.74M	AU$ 14.83M	AU$ 3.74M
Total Debt	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00
Net Debt	AU$ -4.95M	AU$ -4.91M	AU$ -7.22M	AU$ -14.16M	AU$ -3.29M
Total Liabilities	AU$ 85.68K	AU$ 597.36K	AU$ 2.22M	AU$ 223.41K	AU$ 88.53K
Stockholders' Equity	AU$ 5.35M	AU$ 4.69M	AU$ 5.52M	AU$ 14.60M	AU$ 3.65M
Cash Flow
Free Cash Flow	AU$ 42.43K	AU$ -2.30M	AU$ -6.95M	AU$ -2.63M	AU$ -2.28M
Operating Cash Flow	AU$ 44.25K	AU$ -2.30M	AU$ -6.94M	AU$ -2.60M	AU$ -2.28M
Investing Cash Flow	AU$ -1.81K	AU$ 0.00	AU$ -3.87K	AU$ -29.88K	AU$ -2.38K
Financing Cash Flow	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 13.51M	AU$ 960.80K

Currency in AUD

Neuroscientific Biopharmaceuticals Ltd. Earnings and Revenue History

Income Statement >

Neuroscientific Biopharmaceuticals Ltd. Debt to Assets

Balance Sheet >

Neuroscientific Biopharmaceuticals Ltd. Cash Flow

Cash Flow >

Neuroscientific Biopharmaceuticals Ltd. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing